Argentina vs Ecuador: HIV/AIDS deaths averted by antiretroviral therapy
Argentina
4,021 deaths
in 2024
Ecuador
3,034 deaths
in 2024
Argentina rank
46th
Ecuador rank
49th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Argentina
- Ecuador
How they compare
Argentina currently reports 4,021 deaths against 3,034 deaths in Ecuador, a difference of 987 deaths.
That makes Argentina's figure about 1.3 times Ecuador's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Ecuador ahead.
Argentina ranks 46th and Ecuador ranks 49th of 157 countries.
Argentina has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Argentina | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 149.65 deaths | 26.07 deaths | 123.58 deaths | Argentina |
| 2000s | 2,595 deaths | 314.14 deaths | 2,281 deaths | Argentina |
| 2010s | 3,781 deaths | 1,733 deaths | 2,048 deaths | Argentina |
| 2020s | 4,018 deaths | 2,906 deaths | 1,112 deaths | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Argentina or Ecuador?
- Argentina, at 4,021 deaths against 3,034 deaths in Ecuador as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Argentina and Ecuador?
- 987 deaths, with Argentina ahead.
- How many years of comparable data are there for Argentina and Ecuador?
- 35 years are reported by both, from 1990 to 2024.
- How do Argentina and Ecuador rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Argentina ranks 46th and Ecuador ranks 49th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.